title: Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease.
abstract: The intraneuronal accumulation of paired helical filaments in the form of neurofibrillary tangles is one hallmark of the brain pathology in Alzheimer's disease. At certain predilection sites, a small number of similar lesions are also present in the brains of the majority of aged non-demented individuals. As suggested by several studies before, these abnormal cytoskeletal structures contain determinants of microtubule-associated protein tau and ubiquitin. The present study uses a morphological classification of neurofibrillary tangles into different stages of maturation, as suggested by Alzheimer in 1911, and shows by quantitative immunocytochemistry that early stages of neurofibrillary degeneration contain abnormally phosphorylated tau. Immunoreactivity for the altered tau is seen not only in tangles but also in the cytoplasm of some nerve cells lacking neurofibrillary tangles. Similar numbers of such immunoreactive neurons without tangles are present in age-matched non-demented individuals as in Alzheimer cases, but are absent in young controls. In contrast, incorporation of an epitope, recognized by a monoclonal antibody (3-39) raised to paired helical filaments, which is directed against a determinant residing in the 50-65 amino acid residue region of ubiquitin occurs late in the process of tangle maturation and is most pronounced in extracellular 'ghost tangles'. It is suggested that the accumulation of abnormally phosphorylated tau is one of the earliest cytoskeletal changes in the process of tangle formation. Exposure of certain ubiquitin epitopes in the pathological fibers may reflect an unsuccessful attempt of proteolytic degradation.
authors.affiliation: Neurological Institute, University of Vienna, Austria.
authors.forename: C
authors.initials: C
authors.lastname: Bancher
authors.forename: C
authors.initials: C
authors.lastname: Brunner
authors.forename: H
authors.initials: H
authors.lastname: Lassmann
authors.forename: H
authors.initials: H
authors.lastname: Budka
authors.forename: K
authors.initials: K
authors.lastname: Jellinger
authors.forename: G
authors.initials: G
authors.lastname: Wiche
authors.forename: F
authors.initials: F
authors.lastname: Seitelberger
authors.forename: I
authors.initials: I
authors.lastname: Grundke-Iqbal
authors.forename: K
authors.initials: K
authors.lastname: Iqbal
authors.forename: H M
authors.initials: HM
authors.lastname: Wisniewski
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000473:pathology*; D005904:Glial Fibrillary Acidic Protein / Q000032:analysis; D006801:Humans; D008854:Microscopy, Electron; D008869:Microtubule-Associated Proteins / Q000032:analysis*; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000032:analysis*; D009454:Neurofibrils / Q000648:ultrastructure*; D010766:Phosphorylation; D012016:Reference Values; D016875:tau Proteins
chemical_list: D005904:Glial Fibrillary Acidic Protein; D008869:Microtubule-Associated Proteins; D009419:Nerve Tissue Proteins; D016875:tau Proteins